48 Papers
67 Citations
Aung Myat is an academic researcher from Brighton and Sussex University Hospitals NHS Trust. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 10, co-authored 42 publications. Previous affiliations of Aung Myat include Frimley Park Hospital & University Hospital Coventry.
Chat about Author
Papers
Out-of-hospital cardiac arrest: current concepts
TL;DR: The predictors of survival after OHCA and what primary and secondary prevention strategies can be instigated to mitigate the devastating sequelae of this growing public health issue are identified.
460
Revascularisation or medical therapy in elderly patients with acute anginal syndromes: the RINCAL randomised trial.
Adam de Belder,Aung Myat,Jonathan Blaxill,Peter Haworth,Peter O'Kane,Robert Hatrick,Rajesh Aggarwal,Andrew Davie,William J. Smith,Robert Gerber,Jonathan Byrne,Dawn L. Adamson,Fraser Witherow,Osama Alsanjari,Juliet Wright,Derek R. Robinson,David Hildick-Smith +16 more
TL;DR: An intervention-guided strategy did, however, result in less angina, reinfarction and unplanned revascularisation but did not improve survival, and the trial was underpowered to provide a definitive conclusion regarding the primary endpoint.
49
Combination oral antithrombotic therapy for the treatment of myocardial infarction: recent developments
TL;DR: This review, based on literature covering: aspirin, P2Y12 receptor blockers, PAR-1 inhibitors, direct thrombin inhibitors and factor Xa inhibitors, focuses on the recent developments of oral antithrombotic agents including antiplatelet and antithromabin agents.
23
State of the art: Oral antiplatelet therapy
Paul A. Gurbel,Aung Myat,Jacek Kubica,Udaya S. Tantry +3 more
- 01 Jan 2016
TL;DR: This state-of-the-art review focuses on the most recent advances in oral antiplatelet therapy, treading the tightrope of potency versus bleeding risk, the quest to determine the optimal duration of dual anti platelet therapy and future of personalized antiplatelets therapy.
20
Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
Christos P Kotanidis,Greg Mills,Bjørn Bendz,Erlend Sturle Berg,D. Hildick-Smith,Geir Hirlekar,Dejan Milasinovic,Nuccia Morici,Aung Myat,N. Tegn,Juan Sanchis,Stefano Savonitto,Stefano De Servi,Keith A A Fox,Stuart Pocock,V. Kunadian +15 more
TL;DR: No evidence was found that routine invasive treatment for NSTEACS in older patients reduces the risk of a composite of all-cause mortality and MI within 1 year compared with conservative management, however, there is convincing evidence that invasive treatment significantly lowers the risk of repeat MI or urgent revascularisation.
17